<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01829191</url>
  </required_header>
  <id_info>
    <org_study_id>CR-1561AD</org_study_id>
    <nct_id>NCT01829191</nct_id>
  </id_info>
  <brief_title>Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)</brief_title>
  <official_title>Controlling Myopia Progression With Soft Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate whether novel soft contact lens optical designs can slow myopia
      progression
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2008</start_date>
  <completion_date type="Actual">May 1, 2010</completion_date>
  <primary_completion_date type="Actual">May 1, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spherical Equivalent Refractive Error</measure>
    <time_frame>Baseline and every 6 months post-baseline for 2 years</time_frame>
    <description>Cycloplegic spherical equivalent auto refraction of the subject's right eye was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 3 repeated measures, each of which was the average of 3 consecutive readings, was used for the analysis. Higher values in spherical refraction indicate progression in Myopia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Axial Length</measure>
    <time_frame>Baseline and every 6 months for 2 years</time_frame>
    <description>Axial length was measured with the IOLMaster at baseline and every 6 months for 2 years. Five measurements were collected for each visit from the subject's right eye and the average of the five measurements was used for the analysis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">174</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Test Lens A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test lenses will be worn in a daily wear modality</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Lens C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test lenses will be worn in a daily wear modality</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Soft Contact Test Lens A</intervention_name>
    <description>FDA-approved, non-marketed daily disposable soft contact lens, conventional design</description>
    <arm_group_label>Test Lens A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Soft Contact Test Lens C</intervention_name>
    <description>Daily disposable soft contact lens with new optical design</description>
    <arm_group_label>Test Lens C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject must be between 8 and 12 years of age.

          2. At least one of the subject's parents or legal guardian must read and understand
             English or Chinese.

          3. The subject's manifest objective refraction (measured with an auto refractor) must be
             sphere: between -0.25D and -4.50D, and cylinder: &lt;1.50D in each eye.

          4. The subject's best sphere contact lens correction must lie between -0.75D (better of
             the two eyes)and -4.25D (poorer of the two eyes).

          5. The subject's cycloplegic objective refraction must be here: between -0.75D and -4.00D
             cylinder: &lt; or equal to 1.00D in each eye.

          6. The subject must have 1.00D or less difference in spherical equivalent between the two
             eyes with cycloplegic refraction.

          7. The subject must have a spectacle lens best-corrected visual acuity of 0.8 (20/25) or
             better in both eyes.

          8. The subject's parent or legal guardian must read and sign the STAEMENT OF INFORMED
             CONSENT and the subject must read and sign the Child's Assent Form and be provided a
             copy of each form.

          9. The subject must appear able and willing to adhere to the instructions set forth in
             this clinical protocol.

        Exclusion Criteria:

          1. Ocular or systemic allergies or diseases that may interfere with contact lens wear.

          2. Systemic disease or autoimmune disease or use of medications (e.g. antihistamine),
             which may interfere with contact lens wear.

          3. Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal
             staining, or any other abnormality of the cornea, which may contraindicate contact
             lens wear.

          4. Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection that
             might interfere with contact lens wear.

          5. Any ocular infection.

          6. Any corneal distortion resulting from previous hard or rigid gas permeable contact
             lens wear.

          7. Any infectious disease (e.g. hepatitis, tuberculosis) or an immunosuppressive disease
             (e.g. HIV)

          8. Diabetes

          9. Anisometropia of greater than 1.00D by cycloplegic refraction.

         10. Astigmatism of greater than 1.00D in either eye by cycloplegic refraction.

         11. Eye injury or surgery within eight weeks immediately prior to enrollment for this
             study.

         12. Previous refractive surgery, orthokeratology, keratoconus, or other corneal
             irregularity in either eye. Rigid contact lens wearers cannot be enrolled in the study
             unless they are off rigid contact lenses for at least 4 weeks.

         13. Strabismus in either eye.

         14. Pupil or lid abnormality or infection in either eye

         15. Central corneal scar in either eye

         16. Aphakia in either eye

         17. Contraindications to contact lens wear such as dry eye or history of prior
             unsuccessful contact lens wear.

         18. History of participation in prior clinical trials aimed to control myopia progression.

         19. Surgically altered eyes, ocular infection of any type, ocular inflammation.

         20. An anterior chamber angle grade 2 or narrower by the Van Herrick method
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2013</study_first_submitted>
  <study_first_submitted_qc>April 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2013</study_first_posted>
  <results_first_submitted>July 1, 2015</results_first_submitted>
  <results_first_submitted_qc>July 1, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 29, 2015</results_first_posted>
  <last_update_submitted>April 9, 2018</last_update_submitted>
  <last_update_submitted_qc>April 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of those 174 screened subjects, 42 were ineligible to participate in the study and 5 eligible subjects did not randomize to the study arm.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Test Lens A</title>
          <description>Test lenses will be worn in a daily wear modality</description>
        </group>
        <group group_id="P2">
          <title>Test Lens C</title>
          <description>Test lens will be worn in a daily wear modality</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="64"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Relocation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lens discomfort</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lens handling difficulty</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject was fit for ortho - k</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline summary was conducted on all subjects who randomized in the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Test Lens A</title>
          <description>Test lenses will be worn in a daily wear modality</description>
        </group>
        <group group_id="B2">
          <title>Test Lens C</title>
          <description>Test lens will be worn in a daily wear modality</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="63"/>
            <count group_id="B2" value="64"/>
            <count group_id="B3" value="127"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.7" spread="1.1"/>
                    <measurement group_id="B2" value="9.7" spread="1.1"/>
                    <measurement group_id="B3" value="9.7" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="68"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Spherical Equivalent Refractive Error</title>
        <description>Cycloplegic spherical equivalent auto refraction of the subject's right eye was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 3 repeated measures, each of which was the average of 3 consecutive readings, was used for the analysis. Higher values in spherical refraction indicate progression in Myopia.</description>
        <time_frame>Baseline and every 6 months post-baseline for 2 years</time_frame>
        <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
        <group_list>
          <group group_id="O1">
            <title>Test Lens A</title>
            <description>Test lenses will be worn in a daily wear modality</description>
          </group>
          <group group_id="O2">
            <title>Test Lens C</title>
            <description>Test lenses will be worn in a daily wear modality</description>
          </group>
        </group_list>
        <measure>
          <title>Spherical Equivalent Refractive Error</title>
          <description>Cycloplegic spherical equivalent auto refraction of the subject's right eye was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 3 repeated measures, each of which was the average of 3 consecutive readings, was used for the analysis. Higher values in spherical refraction indicate progression in Myopia.</description>
          <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
          <units>diopter (D)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from baseline 6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.386" spread="0.3270"/>
                    <measurement group_id="O2" value="-0.185" spread="0.2873"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 12 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="57"/>
                    <count group_id="O2" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.679" spread="0.5253"/>
                    <measurement group_id="O2" value="-0.548" spread="0.4050"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 18 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.934" spread="0.4761"/>
                    <measurement group_id="O2" value="-0.614" spread="0.4140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 24 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.054" spread="0.4559"/>
                    <measurement group_id="O2" value="-1.080" spread="0.6800"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Axial Length</title>
        <description>Axial length was measured with the IOLMaster at baseline and every 6 months for 2 years. Five measurements were collected for each visit from the subject's right eye and the average of the five measurements was used for the analysis.</description>
        <time_frame>Baseline and every 6 months for 2 years</time_frame>
        <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
        <group_list>
          <group group_id="O1">
            <title>Test Lens A</title>
            <description>Test lenses will be worn in a daily wear modality</description>
          </group>
          <group group_id="O2">
            <title>Test Lens C</title>
            <description>Test lenses will be worn in a daily wear modality</description>
          </group>
        </group_list>
        <measure>
          <title>Axial Length</title>
          <description>Axial length was measured with the IOLMaster at baseline and every 6 months for 2 years. Five measurements were collected for each visit from the subject's right eye and the average of the five measurements was used for the analysis.</description>
          <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
          <units>millimeter (mm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from baseline 6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.172" spread="0.1029"/>
                    <measurement group_id="O2" value="0.061" spread="0.1038"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 12 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="57"/>
                    <count group_id="O2" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.371" spread="0.1471"/>
                    <measurement group_id="O2" value="0.229" spread="0.1581"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 18 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.479" spread="0.2049"/>
                    <measurement group_id="O2" value="0.313" spread="0.1946"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 24 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.545" spread="0.2177"/>
                    <measurement group_id="O2" value="0.514" spread="0.2808"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>All Subjects</title>
          <description>All subjects who eligible to participate in the study whether or not randomized to the study arm.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="132"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="132"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>XU CHENG, PRINCIPAL CLINICAL SCIENTIST</name_or_title>
      <organization>Vistakon, USA</organization>
      <phone>1 904 443-1245</phone>
      <email>xcheng6@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

